Literature DB >> 3804193

Low bone turnover state in primary biliary cirrhosis.

A J Stellon, A Webb, J Compston, R Williams.   

Abstract

To determine whether bone loss in patients with chronic cholestatic liver disease is the consequence of a high or low bone turnover state, 30 female patients with biopsy-proven primary biliary cirrhosis underwent iliac crest biopsy following double tetracycline labeling. The mean trabecular bone volume was decreased as a result of trabecular plate thinning in both the premenopausal (p less than 0.02) and postmenopausal (p less than 0.05) patients, compared to age- and sex-matched controls. Indications that osteoblastic function was impaired included a significantly lower mean wall thickness (p less than 0.01) and mean osteoid seam width (p less than 0.05), and this in association with a decreased mineral appositional rate and prolonged mineralization lag time was suggestive of a defect in matrix synthesis. Further evidence of impaired osteoblastic activity was the significantly lower bone formation rate at both tissue (p less than 0.001) and basic multicellular unit levels (p less than 0.05) in the postmenopausal patients. Total resorption surfaces and fasting urinary calcium/creatinine ratios were significantly increased (p less than 0.005 and 0.05, respectively) in the premenopausal patients and mean interstitial bone thickness reduced in both pre- and postmenopausal patients, suggesting that increased resorption may also contribute to bone loss in primary biliary cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3804193     DOI: 10.1002/hep.1840070127

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

Review 1.  Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

2.  Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease.

Authors:  T Diamond; R Pojer; D Stiel; A Alfrey; S Posen
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

Review 3.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Effect of liver dysfunction on circulating sclerostin.

Authors:  Yumie Rhee; Won Jin Kim; Ki Jun Han; Sung Kil Lim; Se Hwa Kim
Journal:  J Bone Miner Metab       Date:  2013-10-15       Impact factor: 2.626

Review 5.  Bone disease after liver transplantation.

Authors:  M S Losowsky; S H Hussaini
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

6.  Bone histomorphometry and structure in corticosteroid treated chronic active hepatitis.

Authors:  A J Stellon; A Webb; J E Compston
Journal:  Gut       Date:  1988-03       Impact factor: 23.059

7.  Osteoporosis and skeletal fractures in chronic liver disease.

Authors:  T Diamond; D Stiel; M Lunzer; M Wilkinson; J Roche; S Posen
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

8.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

Review 9.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

10.  The heterogeneity of bone disease in cirrhosis: a multivariate analysis.

Authors:  Bronwyn A L Crawford; C Kam; A J Donaghy; G W McCaughan
Journal:  Osteoporos Int       Date:  2003-09-19       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.